These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37584345)

  • 1. Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID-19 pandemic.
    Gaughan AA; MacEwan SR; Rush LJ; Gatti-Mays ME; Pariser AC; McAlearney AS
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1882. PubMed ID: 37584345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences of Patients in Turkey with Breast Cancer throughout the COVID-19 Pandemic and their Coping Mechanisms: A Qualitative Study.
    Özyer Y
    J Relig Health; 2023 Feb; 62(1):662-680. PubMed ID: 36168020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doctoring from home: Physicians' perspectives on the advantages of remote care delivery during the COVID-19 pandemic.
    DePuccio MJ; Gaughan AA; Shiu-Yee K; McAlearney AS
    PLoS One; 2022; 17(6):e0269264. PubMed ID: 35653337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Tonneson JE; Hoskin TL; Day CN; Durgan DM; Dilaveri CA; Boughey JC
    Ann Surg Oncol; 2022 Apr; 29(4):2231-2239. PubMed ID: 34812981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Concerns about COVID-19 and Vaccination: Perspectives from Kidney Transplant Recipients.
    MacEwan SR; Gaughan AA; Dixon GN; Olvera RG; Tarver WL; Rahurkar S; Rush LJ; Schenk AD; Stevens J; McAlearney AS
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Canadian Medical Delays and Preventive Measures on Breast Cancer Experience: A Silent Battle Masked by the COVID-19 Pandemic.
    Fortin J; Rivest-Beauregard M; Defer C; Leblanc M; Thamar Louis LA; Roy CA; Lapierre I; Brunet A; Montreuil M; Marin MF
    Can J Nurs Res; 2023 Mar; 55(1):55-67. PubMed ID: 35484788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates.
    Andrews C; Childers TC; Wiseman KD; Lawhon V; Ingram S; Smith ML; Wolff AC; Wagner L; Rocque GB
    BMC Cancer; 2022 Feb; 22(1):141. PubMed ID: 35120494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 Pandemic on Surgical Breast Cancer Patients Undergoing Neoadjuvant Therapy: A Multicentric Study.
    Vanni G; Pellicciaro M; Combi F; Papi S; Materazzo M; Segattini S; Rizza S; Chiocchi M; Perretta T; Meucci R; Portarena I; Pistolese CA; Ielpo B; Campanelli M; Lisi G; Chiaravalloti A; Tazzioli G; Buonomo OC
    Anticancer Res; 2021 Sep; 41(9):4535-4542. PubMed ID: 34475080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes.
    Potter DA; Thomas A; Rugo HS
    Clin Cancer Res; 2021 Aug; 27(16):4486-4490. PubMed ID: 34108186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's perception about the discovery of breast cancer amid the covid-19 pandemic.
    Carvalho SM; Andrade CA; Ferreira MBLS; de Souza KSS; Grincenkov FRDS
    PLoS One; 2023; 18(4):e0282610. PubMed ID: 37104251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The experience of Australian general practice patients at high risk of poor health outcomes with telehealth during the COVID-19 pandemic: a qualitative study.
    Javanparast S; Roeger L; Kwok Y; Reed RL
    BMC Fam Pract; 2021 Apr; 22(1):69. PubMed ID: 33832422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
    Duarte MBO; Argenton JLP; Carvalheira JBC
    JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives.
    Rocco N; Montagna G; Di Micco R; Benson J; Criscitiello C; Chen L; Di Pace B; Esgueva Colmenarejo AJ; Harder Y; Karakatsanis A; Maglia A; Mele M; Nafissi N; Ferreira PS; Taher W; Tejerina A; Vinci A; Nava M; Catanuto G
    Oncologist; 2021 Jan; 26(1):e66-e77. PubMed ID: 33044007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Pandemic Stressors and Psychological Symptoms in Breast Cancer Patients.
    Massicotte V; Ivers H; Savard J
    Curr Oncol; 2021 Jan; 28(1):294-300. PubMed ID: 33430131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trend and direct costs of screening and chemotherapy treatment of breast cancer in the new coronavirus pandemic: total and interrupted time series study.
    Hyeda A; da Costa ÉSM; Kowalski SC
    BMC Health Serv Res; 2022 Dec; 22(1):1466. PubMed ID: 36461119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How did women with breast cancer experience the first wave of the COVID-19 pandemic? A qualitative study.
    Savard J; Jobin-Théberge A; Massicotte V; Banville C
    Support Care Cancer; 2021 Oct; 29(10):5721-5727. PubMed ID: 33725173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population.
    Caswell-Jin JL; Shafaee MN; Xiao L; Liu M; John EM; Bondy ML; Kurian AW
    Breast Cancer Res Treat; 2022 Jul; 194(2):475-482. PubMed ID: 35624175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with adjuvant systemic anti-cancer treatment discontinuation for early breast cancer during the COVID-19 pandemic.
    Gatfield ER; Bataineh A; El Kurdi B; Mukesh MB; Loo SW
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13668. PubMed ID: 35950493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. '…the way it was staffed during COVID is the way it should be staffed in real life…': a qualitative study of the impact of COVID-19 on the working conditions of junior hospital doctors.
    Byrne JP; Creese J; Matthews A; McDermott AM; Costello RW; Humphries N
    BMJ Open; 2021 Aug; 11(8):e050358. PubMed ID: 34373310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.